Loading clinical trials...

Uncemented Hemiarthroplasty, Radiological Features Comparing Lateral Versus Anterolateral Approach | Clinical Trials | Clareo Health

COMPLETEDNA

Uncemented Hemiarthroplasty, Radiological Features Comparing Lateral Versus Anterolateral Approach

Uncemented Hemiarthroplasty, Radiological Features Comparing Lateral Versus Anterolateral Approach: A Follow-up of a Randomized Controlled Trial.

NCT03974698•Sorlandet Hospital HF

View on ClinicalTrials.gov

Summary

Uncemented Hemiarthroplasty, Radiological Features Comparing Lateral Versus Anterolateral Approach. Comparing leg length discrepancy, femoral offset, valgus/varus position of the stem. Also is there a difference in heterotopic ossification at 12 months.

Detailed Description

Between January 2014 and July 2017 a RCT was conducted at Sorlandet Hospital Kristiansand, Norway. The trial was approved by the regional ethics committee (2013/1853/REK) and registered at ClinicalTrials.gov (ClinicalTrials.gov Identifier NCT02028468). This study is a follow-up on the same study population. 150 patients (70 to 90 years) with a displaced femoral neck fracture was randomized to be operated With either anterolateral og Direct lateral surgical approach. Investigators want to compare the radiological features of the femoral stem between the two Groups.

Eligibility

Age

70 - 90 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients between 70 and 90 years of age with displaced femoral neck fractures
•Intact cognitive function
•Ability to walk with or without a walking aid prior to falling.

Exclusion Criteria

•Dementia
•Fractures in pathologic bone
•Patients not belonging to the hospital community
•Patients with sepsis or local infection

Locations (1)

Sorlandet Hospital

Kristiansand, Norway

Key Dates

Start Date

February 1, 2014

Primary Completion Date

July 31, 2017

Completion Date

July 31, 2018

Last Updated

January 25, 2021

Enrollment

150

ACTUAL participants

Conditions

Femoral Neck FracturesHemiarthroplastyHeterotopic Ossification

Interventions

Hemiarthroplasty

PROCEDURE

Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

NCT06565910

Femoral Neck FracturesFemur Head Necrosis+1 more

View study

RECRUITINGNA

Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia

NCT07442721

Hip ArthroplastyHip Fracture Surgeries+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 25, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Uncemented Hemiarthroplasty, Radiological Features Comparing Lateral Versus Anterolateral Approach

Inclusion Criteria

Exclusion Criteria

Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia

Evaluation of Fracture Migration After Internal Fixation of Femoral Neck Fractures in Younger Adults: A Clinical RCT Using RSA

A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.

Opioid-Free Pain Treatment in Trauma Patients

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture